Kapur Anil's Insider Trades & SAST Disclosures
Kapur Anil's most recent trade in Nurix Therapeutics Inc was a trade of 25,000 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on May 19, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kapur Anil.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nurix Therapeutics Inc | Anil Kapur | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 25,000 | 25,000 | - | - | Director Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Anil Kapur | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2024 | 50,000 | 50,000 | - | - | Director Stock Option (right to buy) | |
| Verastem Inc | Anil Kapur | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Verastem Inc | Anil Kapur | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 8,333 | 8,333 (0%) | 0% | 0 | Common Stock | |
| Geron Corp. | Anil Kapur | EVP, Corp Strategy & CCO | 10 Jun 2024 | 421,875 | 421,875 (0%) | 0% | 1.1 | 447,188 | Common Stock | |
| Geron Corp. | Anil Kapur | EVP, Corp Strategy & CCO | 10 Jun 2024 | 421,875 | 0 (0%) | 0% | 4.6 | 1,959,609 | Common Stock | |
| Geron Corp. | Anil Kapur | EVP, Corp Strategy & CCO | 10 Jun 2024 | 421,875 | 328,125 | - | - | Stock Option (right to buy) | ||
| Geron Corp. | Anil Kapur | EVP, Corp Strategy & CCO | 06 Jun 2024 | 250,000 | 250,000 | - | - | Employee Stock Option (right to buy) | ||
| Geron Corp. | Kapur Anil | EVP, CORP STRATEGY & CCO | 14 Feb 2024 | 750,000 | 750,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Verastem Inc | Anil Kapur | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Anil Kapur | EVP, Corp Strategy & CCO | 22 Feb 2023 | 625,000 | 625,000 | - | - | Employee Stock Option (right to buy) | ||
| Geron Corp. | Anil Kapur | EVP, Corp Strategy & CCO | 30 Dec 2022 | 6,021 | 53,216 (0%) | 0% | 1.1 | 6,683 | Common Stock | |
| Verastem Inc | Anil Kapur | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2022 | 163,185 | 163,185 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Anil Kapur | EVP, Corp Strategy & CCO | 16 Feb 2022 | 750,000 | 750,000 | - | - | Employee Stock Option (right to buy) | ||
| Geron Corp. | Anil Kapur | EVP, Corp Strategy & CCO | 02 Feb 2021 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges